Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol

Parkinsonism and Related Disorders

Volumn 14, Issue SUPPL.2, 2008, Pages

  Meredith, Gloria E ^a   Totterdell, Susan ^b   Potashkin, Judith A ^a   Surmeier, D James ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alpha synuclein; Dopamine; Grid test; Isradipine; L type calcium channel; Probenecid; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; CALCIUM CHANNEL BLOCKING AGENT; GLUTAMIC ACID; ISRADIPINE; PLACEBO; PROBENECID;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DEATH; CELL INCLUSION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOREACTIVITY; INFLAMMATION; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STRIATONIGRAL DEGENERATION; VALIDITY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; INFLAMMATION; MICE; NEUROTOXINS; PARKINSON DISEASE; TYROSINE 3-MONOOXYGENASE;

EID: 47049122191     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.04.012     Document Type: Review

References (14)

1. Meredith G.E., and Kang U.J. Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord 21 (2006) 1595-1606
2. Petroske E., Meredith G.E., Callen S., Totterdell S., and Lau Y.S. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106 (2001) 589-601
3. Chan C.S., Guzman J.N., Ilijic E., Mercer J.N., Rick C., Tkatch T., et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447 (2007) 1081-1086
4. Potashkin J.A., Kang U.J., Loomis P.A., Jodelka F.M., Ding Y., and Meredith G.E. MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9. Brain Res 28 (2007) 1-10
5. Tillerson J.L., and Miller G.W. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neurosci Meth 123 (2003) 189-200
6. Meredith G.E., Dervan A.G., and Totterdell S. Activated microglial persist in the substantia nigra of a chronic MPTP mouse model of Parkinson's disease. In: Bolam J.P., Ingham C.A., and Magill P. (Eds). Basal ganglia VIII (2005), Plenum Press, . New York, NY 341-348
7. Meredith G.E., Totterdell S., Petroske E., Santa Cruz K., Callison Jr. R.C., and Lau Y.S. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 956 (2002) 156-165
8. Jin J., Meredith G.E., Chen L., Zhou Y., Xu J., Shie F.S., et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Mol Brain Res 134 (2005) 119-138
9. Fornai F., Schluter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102 (2005) 3413-3418
10. Shimoji M., Zhang L., Mandir A.S., Dawson V.L., and Dawson T.M. Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease. Brain Res Mol Brain Res 134 (2005) 103-108
11. Yazdani U., German D.C., Liang C.L., Manzino L., Sonsalla P.K., and Zeevalk G.D. Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP(+)). Exp Neurol 200 (2006) 172-183
12. Meredith G.E., Halliday G.M., and Totterdell S. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation. Parkinsonism Relat Disord 10 (2004) 191-202
13. Mercuri N.B., Bonci A., Calabresi P., Stratta F., Stefani A., and Bernardi G. Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. Br J Pharmacol 113 (1994) 831-838
14. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366 (1998) 211-223